Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

RayzeBio Expands Leadership Team with Arvind Kush as Chief Financial Officer; and Aubrey Haddach, J.D., as General Counsel

RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced the addition of Arvind Kush and Aubrey Haddach to its senior management team.

  • Arvind Kush – Chief Financial Officer. With over 13 years as an investment banker, Arvind joins RayzeBio from Bank of America Securities. Previously, he was a Managing Director in the healthcare investment banking group, advising biotechnology companies on financing and strategic initiatives. Arvind has worked on over $100 billion in M&A transactions and over $12 billion in equity and equity-linked capital raises.
  • Aubrey Haddach, J.D. – General Counsel and Secretary. Aubrey has over 25 years of combined industry experience beginning in laboratory chemistry and then transitioning into law in 2001. Before joining RayzeBio, her prior roles included General Counsel, Corporate Secretary, and Chief Privacy Officer at private and public companies. From 2003 to 2018, Aubrey was outside counsel to a variety of clients ranging from small businesses to Fortune 500 companies, focusing on intellectual property and corporate transactions in life sciences.

“Arvind and Aubrey bring a tremendous amount of talent and experience to our company, especially in the finance, strategy, and legal disciplines,” said Ken Song, M.D., President and CEO of RayzeBio. “Their expertise will be invaluable as we continue to build a leading radiopharmaceutical company.”

Arvind added, “RayzeBio is revolutionizing the field of targeted radiopharmaceuticals. I am honored and excited to be part of this amazing team.”

Aubrey further added, “The company is making tremendous strides in unlocking the potential of radiopharmaceuticals. I look forward to partnering with the rest of management team to advance the Company’s mission.”

About RayzeBio

RayzeBio is a biotechnology company focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. With a focus on clinically validated solid tumor targets, RayzeBio is developing novel drug conjugates to deliver potent therapeutic radioisotopes such as Actinium-225, an alpha-emitter. The company is backed by a syndicate of sophisticated healthcare investors and was established in 2020. For additional information, please visit www.rayzebio.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.